Amerisource Health Services LLC recalls Benzonatate Capsules
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Superpotent drug: Assay results were slightly above specification at the time zero point.
- Products
-
- Benzonatate Capsules
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 6,344 cartons
- About this recall
- Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11